<DOC>
	<DOC>NCT01744860</DOC>
	<brief_summary>This non-interventional study will compare the Cobas BRAF V600 mutation assay with in-house methods used in molecular laboratories for the assessment of the BRAF mutation status in melanoma tumor samples. No patients will be enrolled in this study. Data will be collected for approximately 6 months.</brief_summary>
	<brief_title>Comparison of In-House Methods and Cobas BRAF V600 Mutation Assay in Melanoma Tumor Samples</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<criteria>No patients are enrolled. Use of tumor samples only. Histologically proven melanoma tumor sample Any type of tumor sample: biopsy or surgical specimen of primary tumor or metastasis Tumor samples must be fixed and paraffinembedded. No patients are enrolled. Use of tumor samples only. Fixative unknown</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>